CLOV — Clover Health Investments Cashflow Statement
0.000.00%
Last trade - 00:00
- $314.81m
- $16.49m
- $2.03bn
- 30
- 62
- 53
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.018 | -6.74 | -588 | -340 | -213 |
Depreciation | |||||
Non-Cash Items | — | -0.117 | 112 | 130 | 158 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | — | 4.63 | 193 | -77.6 | -62.7 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.018 | -2.23 | -282 | -286 | -116 |
Capital Expenditures | — | — | -0.723 | -4.47 | -0.584 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | -828 | -435 | 99.6 | 141 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | — | -828 | -435 | 95.1 | 140 |
Financing Cash Flow Items | 0.018 | -0.776 | 666 | 82.4 | -28.8 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.018 | 858 | 925 | 77.5 | -33.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 28 | 208 | -114 | -9.72 |